drugset / Trial / NCT00548938

Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM

NCT00548938

Phase 2 Terminated 40 enrolled Methodist Healthcare - Memphis
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and efficacy of the combination of Gliadel wafers plus surgery and limited field radiation therapy with concomitant temozolomide followed by temozolomide given at an extended dose schedule (metronomic schedule) in patients undergoing initial surgery for newly-diagnosed high grade glioma.

Timeline

Start
2007-10
Primary completion
2009-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Gliadel Wafer Unknown Other
Subject Temozolomide Small molecule 75 mg/m2

Indications